Figure 4.
Cost-effectiveness acceptability curve of fondaparinux and rivaroxaban compared with argatroban.

Cost-effectiveness acceptability curve of fondaparinux and rivaroxaban compared with argatroban.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal